Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Inovio Pharmaceuticals Inc (NASDAQ: INO) was $2.29 for the day, up 1.78% from the previous closing price of $2.25. In other words, the price has increased by $1.78 from its previous closing price. On the day, 1.11 million shares were traded. INO stock price reached its highest trading level at $2.32 during the session, while it also had its lowest trading level at $2.188.
Ratios:
Our analysis of INO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.88 and its Current Ratio is at 3.88. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.14.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on May 14, 2024, initiated with a Overweight rating and assigned the stock a target price of $20.
On January 25, 2024, Oppenheimer Upgraded its rating to Outperform which previously was Perform but kept the price unchanged to $4.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INO now has a Market Capitalization of 82669000 and an Enterprise Value of 26408250. For the stock, the TTM Price-to-Sale (P/S) ratio is 413.32 while its Price-to-Book (P/B) ratio in mrq is 0.81. Its current Enterprise Value per Revenue stands at 44.619 whereas that against EBITDA is -0.23.
Stock Price History:
The Beta on a monthly basis for INO is 0.90, which has changed by -0.63414633 over the last 52 weeks, in comparison to a change of 0.24440956 over the same period for the S&P500. Over the past 52 weeks, INO has reached a high of $14.75, while it has fallen to a 52-week low of $1.74. The 50-Day Moving Average of the stock is -26.11%, while the 200-Day Moving Average is calculated to be -68.21%.
Shares Statistics:
INO traded an average of 931.28K shares per day over the past three months and 1344290 shares per day over the past ten days. A total of 36.10M shares are outstanding, with a floating share count of 35.80M. Insiders hold about 0.82% of the company’s shares, while institutions hold 26.78% stake in the company. Shares short for INO as of 1730332800 were 3504745 with a Short Ratio of 4.66, compared to 1727654400 on 3342839. Therefore, it implies a Short% of Shares Outstanding of 3504745 and a Short% of Float of 13.59.
Earnings Estimates
The current assessment of Inovio Pharmaceuticals Inc (INO) involves the perspectives of 5.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.67, with high estimates of -$0.67 and low estimates of -$0.67.
Analysts are recommending an EPS of between -$3.81 and -$4.71 for the fiscal current year, implying an average EPS of -$4.21. EPS for the following year is -$3.09, with 5.0 analysts recommending between -$2.16 and -$4.45.
Revenue Estimates
For the next quarter, 6 analysts are estimating revenue of $100k. There is a high estimate of $100k for the next quarter, whereas the lowest estimate is $100k.
A total of 6 analysts have provided revenue estimates for INO’s current fiscal year. The highest revenue estimate was $200k, while the lowest revenue estimate was $100k, resulting in an average revenue estimate of $125.5k. In the same quarter a year ago, actual revenue was $832.01k
